Praziquantel

Таблетки By prescription

Antihelminthic agent, a derivative of pyrazinisoquinoline. It has a broad spectrum of action, which includes many trematodes and cestodes.

Praziquantel

Indications

Praziquantel is indicated for use in adults and children over 4 years of age for the treatment of infections caused by:

- various species of schistosomes (Schistosoma haematobium, S. mansoni, S. intercalatum, S. japonicum, S. mekongi);
- liver flukes (Clonorchis sinensis, Opistorchis viverrini);
- pulmonary biped (Paragonimus westermani, other species).

Contraindications

Do not take Praziquantel:
- If you are allergic to praziquantel or any other components of the medicine (listed in section 6 of the leaflet);
- If you have ocular cysticercosis;
- if you are taking powerful inducers (stimulants) of cytochrome P450 (for example, the antibiotic rifampicin) at the same time;
Praziquantel is contraindicated for the treatment of children under 4 years of age (safety and efficacy have not been established).

Usage

Always take the drug in full compliance with the recommendations of your doctor. If in doubt, consult your doctor.

Recommended dose:

Doses of Praziquantel are strictly individualised and depend on the type of pathogen.

In the treatment of infections caused by trematodes, the therapeutic activity and tolerability of the active substance can be increased by splitting the total dose and taking the drug at 4-hour intervals. All single doses should be at least 20 mg/kg body weight.

The film-coated tablet is divided into 4 doses of 150 mg of praziquantel each, allowing the dosage to be precisely matched to the patient's body weight.
Unless otherwise prescribed, the following daily doses are recommended:

Adults:

Schistosoma haematobium, Schistosoma mansoni and Schistosoma intercalatum: 40 mg/kg body weight, divided into 1-2 doses. Duration of treatment is 1 day.


Schistosoma japonicum and Schistosoma mekongi: 60 mg/kg body weight, divided into 2-3 doses. Duration of treatment - 1 day.

Clonorchis sinensi and Opisthorchis viverrini: 75 mg/kg body weight divided into 3 doses. Duration of treatment - 1-3 days.


Paragonimus westermani and other species of pulmonary parasites: 75 mg/kg body weight divided into 3 doses. Duration of treatment - 2-3 days.

Use in children and adolescents

Children over 4 years of age

Schistosoma haematobium, Schistosoma mansoni and Schistosoma intercalatum: 40 mg/kg body weight, divided into 1-2 doses. Duration of treatment is 1 day.
Schistosoma japonicum and Schistosoma mekongi: 60 mg/kg body weight divided into 3 doses. Duration of treatment - 1 day.
Clonorchis sinensis and Opisthorchis viverrini: 75 mg/kg body weight, divided into 3 doses with intervals of 4 hours. Duration of treatment - 1 day.
Paragonimus westermani and other species of pulmonary parasites: 75 mg/kg body weight, divided into 3 doses with intervals of 4 hours. Duration of treatment - 1 day.

Download full instruction

Report undesirable reaction

If you have information about undesirable reaction after taking the drug

Hotline +7 (495) 984-28-47

Report

Have questions? Contact Us

Has contraindications. Needs specialist overview.

Please read our privacy policy

The present personal data processing policy is drawn up in accordance with the requirements of the Federal Law of July 27, 2006. No. 152-FЗ “On Personal Data” and determines the procedure for processing personal data and measures to ensure the security of personal data of Mir-Pharm LLC (hereinafter referred to as the Operator).

The operator sets as his most important goal and condition for the implementation of his activities the respect for the rights and freedoms of man and citizen in the processing of his personal data, including the protection of the rights to privacy, personal and family confidentiality.

The Operator's policy regarding the processing of personal data (hereinafter - the Policy) applies to all information that the Operator can receive about visitors of the website https://mirpharm.ru.

The user can get any clarification on issues of interest regarding the processing of his personal data by contacting the Operator via e-mail info@mirpharm.ru.

The current version of the Policy is located in free access on the Internet at https://mirpharm.ru/policy.

This document will reflect any changes in the policy of processing personal data by the Operator. The policy is valid indefinitely until it is replaced with a new version.